Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
IL-1β 和 VEGF-A 串扰的解偶联导致慢性糖尿病缺血的动脉生成反应受损
基本信息
- 批准号:10579818
- 负责人:
- 金额:$ 34.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-20 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgingAngioplastyAtherosclerosisBiologyBlood VesselsBlood flowBone MarrowBone Marrow InvolvementBypassCardiopulmonaryCenters of Research ExcellenceChronicClinicalDataDiabetes MellitusDiabetic mouseDisease modelExperimental Diabetes MellitusGoalsImpairmentInflammationInflammatoryInjuryInterleukin-1 betaIschemiaLigationMechanicsModificationMorbidity - disease rateMusNon-Insulin-Dependent Diabetes MellitusOperative Surgical ProceduresPathway interactionsPeripheral arterial diseaseProductionProtein IsoformsRecoveryRisk FactorsRoleSignal TransductionTissuesTranscriptional RegulationVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth FactorsVegf inhibitionagedangiogenesisdiabeticfemoral arterymacrophagemortalitynovelpreclinical studyresponse
项目摘要
Peripheral artery disease (PAD) caused by atherosclerosis leads to considerable morbidity and mortality
throughout the world, in large part, due to tissue damage from both acute and chronic occlusive ischemia.
Current treatments are limited to the modification of risk factors and mechanical revascularization by
surgical bypass or angioplasty. Preclinical studies have identified mechanisms involving bone marrow
derived macrophage (BMDM)-dependent angiogenesis in an inflammation suppressed state, but there is
also a role for inflammatory macrophages during acute injury to promote effective angiogenesis. We
recently defined a novel IL-1 B-dependent transcriptional regulation of the pro-angiogenic isoform of
VEGF-A. Primary macrophages with deletion of IL-1 B demonstrate impaired expression of VEGF-A, and
consequently, macrophage IL-1 beta-deleted mice have impaired angio/ arteriogenesis. Recent
preliminary data identified that VEGF-R2 (relative to VEGFR1) expression is also elevated in the
inflammatory M1 state and is associated with elevations in IL-1 beta and VEGF-A. Inhibition of
VEGF-R2 signaling led to reduced VEGF-A expression despite stable IL-1 beta levels, suggesting an
uncoupling of the relationship between IL-1 beta and VEGF-A . Additional preliminary data demonstrated
that aged (52-week-old) mice or mice with experimental diabetes have reductions angio/ arteriogenesis,
using a PAD model of femoral artery ligation that involves macrophage-directed blood flow recovery.
Combined aging with chronic diabetes led to further reductions in blood flow recovery consequent to
impaired angiogenesis. Further BMDMs from aged, diabetic mice demonstrated an uncoupling of IL-1 beta
and VEGF-A expression, with modest reductions in IL-1 beta and yet severe and disproportionately
reduced VEGF-A expression. VEGF-R2 was decreased in aged, diabetic BMDMs. Uncoupling of
macrophage IL-1 beta-VEGF-A signaling contributes to impairment of inflammatory angio/arteriogenesis in
the setting of long-term type 2 diabetes. Our study aims seek to define the mechanism whereby
VEGF-R2 facilitates IL-1 beta-dependent VEGF-A production and consequent arteriogenesis and to
determine the impairments in this pathway caused by aging and long-term diabetes with the goal of
intervening to recover effective angiogenesis in the appropriate clinical context.
由动脉粥样硬化引起的外周动脉疾病(PAD)导致相当高的发病率和死亡率
在世界范围内,很大程度上是由于急性和慢性闭塞性缺血造成的组织损伤。
目前的治疗仅限于改变危险因素和机械血运重建
外科搭桥手术或血管成形术。临床前研究已确定涉及骨髓的机制
炎症抑制状态下的衍生巨噬细胞(BMDM)依赖性血管生成,但存在
炎症巨噬细胞在急性损伤期间也发挥着促进有效血管生成的作用。我们
最近定义了一种新的 IL-1 B 依赖性转录调节促血管生成亚型
VEGF-A。 IL-1 B 缺失的原代巨噬细胞表现出 VEGF-A 表达受损,并且
因此,巨噬细胞 IL-1 β 缺失的小鼠血管/动脉生成受损。最近的
初步数据表明,VEGF-R2(相对于 VEGFR1)的表达在
炎症 M1 状态并与 IL-1 β 和 VEGF-A 升高相关。抑制
尽管 IL-1 β 水平稳定,但 VEGF-R2 信号传导导致 VEGF-A 表达减少,这表明
IL-1β 和 VEGF-A 之间关系的解偶联。已证实的其他初步数据
老年(52周龄)小鼠或患有实验性糖尿病的小鼠血管/动脉生成减少,
使用涉及巨噬细胞引导血流恢复的股动脉结扎 PAD 模型。
衰老与慢性糖尿病相结合导致血流恢复进一步减少
血管生成受损。来自老年糖尿病小鼠的进一步 BMDM 证明了 IL-1 β 的解偶联
和 VEGF-A 表达,IL-1 β 适度减少,但严重且不成比例地减少
VEGF-A 表达减少。老年糖尿病 BMDM 中 VEGF-R2 降低。解耦
巨噬细胞 IL-1 beta-VEGF-A 信号传导导致炎症血管/动脉生成受损
长期2型糖尿病的情况。我们的研究目的是寻求定义机制
VEGF-R2 促进 IL-1 β 依赖性 VEGF-A 的产生和随后的动脉生成,并促进
确定衰老和长期糖尿病引起的该通路损伤,目标是
在适当的临床背景下进行干预以恢复有效的血管生成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth O Harrington其他文献
Elizabeth O Harrington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth O Harrington', 18)}}的其他基金
“Phenotyping Heart Failure with Preserved Ejection Fraction Using Non- Invasive Biomarkers
使用非侵入性生物标志物通过保留射血分数对心力衰竭进行表型分析
- 批准号:
10624557 - 财政年份:2022
- 资助金额:
$ 34.98万 - 项目类别:
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
IL-1β 和 VEGF-A 串扰的解偶联导致慢性糖尿病缺血的动脉生成反应受损
- 批准号:
10549633 - 财政年份:2021
- 资助金额:
$ 34.98万 - 项目类别:
The Role of NPR-C In Modulation Of Acute Lung Injury
NPR-C 在调节急性肺损伤中的作用
- 批准号:
9235305 - 财政年份:2015
- 资助金额:
$ 34.98万 - 项目类别:
相似国自然基金
角质形成细胞源性外泌体携载miR-31调控成纤维细胞ERK通路抗皮肤老化的作用机制
- 批准号:82373460
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
塑料光老化介导的微(纳)塑料形成和光解产物释放对雄性生殖内分泌的干扰研究
- 批准号:22376195
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
苯乙烯-丁二烯共聚物力化学老化的自由基捕获光环加成协同修复机制
- 批准号:22303065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System)
通过植入多个可扩张球囊、药物洗脱生物可吸收支架(股动脉血管支架系统)经皮治疗外周动脉闭塞性疾病
- 批准号:
10706525 - 财政年份:2022
- 资助金额:
$ 34.98万 - 项目类别:
Infusible Extracellular Matrix for Treating Myocardial Infarction
可溶性细胞外基质治疗心肌梗塞
- 批准号:
10642880 - 财政年份:2022
- 资助金额:
$ 34.98万 - 项目类别:
Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged
将靶向去甲基化与非编码 RNA 介导的 mRNA 稳定相结合作为治疗老年人动脉生成的策略
- 批准号:
10826740 - 财政年份:2022
- 资助金额:
$ 34.98万 - 项目类别:
PERCUTANEOUS TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH IMPLANTATION OF MULTIPLE, BALLOON-EXPANDABLE, DRUG-ELUTING BIORESORBABLE SCAFFOLDS (the Efemoral Vascular Scaffold System)
通过植入多个可扩张球囊、药物洗脱生物可吸收支架(股动脉血管支架系统)经皮治疗外周动脉闭塞性疾病
- 批准号:
10545226 - 财政年份:2022
- 资助金额:
$ 34.98万 - 项目类别:
Infusible Extracellular Matrix for Treating Myocardial Infarction
可溶性细胞外基质治疗心肌梗死
- 批准号:
10504948 - 财政年份:2022
- 资助金额:
$ 34.98万 - 项目类别: